ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

September 5, 1997